News
Apathy as an indicator of progression in Huntington’s disease
IDIBELL-UB researchers associate changes in white matter connectivity in different subtypes of apathy, one of the most common psychiatric syndromes in Huntington’s disease (HD)
Higher consumption of soft drinks linked with an increased risk of mortality
This is the main highlight of a study published today in JAMA Internal Medicine, based on a population of about 452,000 people of both genders from 10 European countries followed over a period of 16 years.
Professional-guided online cancer communities improve well-being, quality of life and reduce emotional distress and the risk of hospitalizations
Digital transformation and online resources are changing the relationship between healthcare professionals and their patients, and the way medical care is provided. The change from a traditional paternalistic model of medical care to a relational one, focused on the needs of patients and their families, promotes the empowerment of the user, responsibility for their illness, […]
Researchers from the IDIBELL and the University of Barcelona describe a new treatment that could cope with two bone diseases
The study describes the ability of a PI3-kinase inhibitor to combat Heterotopic Ossification and Fibrodysplasia Ossificans Progressiva in murine preclinical models
EXTENDED DEADLINE — Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine
1.- Background The Centre for Regenerative Medicine of Barcelona (CMR[B]), together with the Biomedical Research Institute of Bellvitge (IDIBELL), at the behest of the Catalan Government(1), have launched the Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia – P-CMR[C]. The fundamental mission of the P-CMR[C] is to advance the implementation of regenerative medicine strategies by conducting research […]
An inflammatory diet correlates with colorectal cancer risk
The risk of developing colorectal cancer for individuals that follow a pro-inflammatory diet is two times higher than usual
Scientists Determine a mechanism that would allow treating more aggressive tumors
The study has proven the viability of this approach by studying in mice the evolution of metastatic colon tumors of human patients
Researchers at IDIBELL-ICO describe a new resistance mechanism to therapies that prevent the formation of blood vessels
The mechanism does not activate the reduction of oxygen in the cells of the tumor, contrary to what common drugs, called anti-angiogenic, usually cause